Eosinophilic oesophagitis: Current evidence-based diagnosis and treatment

Gastroenterología y Hepatología (English Edition) - Tập 41 - Trang 281-291 - 2018
Alfredo J. Lucendo1,2, Javier Molina-Infante2,3
1Sección de Aparato Digestivo, Hospital General de Tomelloso, Tomelloso, Ciudad Real, Spain
2Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas CIBEREHD, Spain
3Servicio de Aparato Digestivo, Hospital Universitario San Pedro de Alcántara, Cáceres, Spain

Tài liệu tham khảo

Attwood, 1993, Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome, Dig Dis Sci, 38, 109, 10.1007/BF01296781 Straumann, 1994, [Idiopathic eosinophilic esophagitis: a frequently overlooked disease with typical clinical aspects and discrete endoscopic findings], Schweiz Med Wochenschr, 124, 1419 Arias, 2016, Systematic review with meta-analysis: the incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies, Aliment Pharmacol Ther, 43, 3, 10.1111/apt.13441 Lucendo, 2017, Systematic review: health-related quality of life in children and adults with eosinophilic oesophagitis—measure instruments and determinant factors, Aliment Pharmacol Ther, 46, 401, 10.1111/apt.14194 Furuta, 2007, Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment, Gastroenterology, 133, 1342, 10.1053/j.gastro.2007.08.017 Liacouras, 2011, Eosinophilic esophagitis: updated consensus recommendations for children and adults, J Allergy Clin Immunol, 128, 3, 10.1016/j.jaci.2011.02.040 Dellon, 2013, American College of Gastroenterology (ACG) clinical guideline: evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE), Am J Gastroenterol, 108, 679, 10.1038/ajg.2013.71 Papadopoulou, 2014, Management guidelines of eosinophilic esophagitis in childhood, J Pediatr Gastroenterol Nutr, 58, 107, 10.1097/MPG.0b013e3182a80be1 Lucendo, 2017, Quality assessment of clinical practice guidelines for eosinophilic esophagitis using the AGREE II instrument, Expert Rev Gastroenterol Hepatol, 11, 383, 10.1080/17474124.2017.1285696 Lucendo, 2017, Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults, United Eur Gastroenterol J, 5, 335, 10.1177/2050640616689525 Molina-Infante, 2017, Proton pump inhibitor-responsive esophageal eosinophilia: still a valid diagnosis?, Curr Opin Gastroenterol, 33, 285, 10.1097/MOG.0000000000000371 Molina-Infante, 2011, Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults, Clin Gastroenterol Hepatol, 9, 110, 10.1016/j.cgh.2010.09.019 Molina-Infante, 2016, Proton pump inhibitor-responsive oesophageal eosinophilia: an entity challenging current diagnostic criteria for eosinophilic oesophagitis, Gut, 65, 521, 10.1136/gutjnl-2015-310991 Arias, 2013, Prevalence of eosinophilic oesophagitis in adult patients in a central region of Spain, Eur J Gastroenterol Hepatol, 25, 208, 10.1097/MEG.0b013e32835a4c95 Molina-Infante, 2017, Rising incidence and prevalence of adult eosinophilic esophagitis in midwestern Spain (2007–2016), United Eur Gastroenterol J Veerappan, 2009, Prevalence of eosinophilic esophagitis in an adult population undergoing upper endoscopy: a prospective study, Clin Gastroenterol Hepatol, 7, 420, 10.1016/j.cgh.2008.10.009 Sperry, 2011, Esophageal foreign-body impactions: epidemiology, time trends, and the impact of the increasing prevalence of eosinophilic esophagitis, Gastrointest Endosc, 74, 985, 10.1016/j.gie.2011.06.029 Kerlin, 2007, Prevalence of eosinophilic esophagitis in adults with food bolus obstruction of the esophagus, J Clin Gastroenterol, 41, 356, 10.1097/01.mcg.0000225590.08825.77 Hurtado, 2011, Etiology of esophageal food impactions in children, J Pediatr Gastroenterol Nutr, 52, 43, 10.1097/MPG.0b013e3181e67072 Hill, 2013, Prevalence of eosinophilic esophagitis in children with refractory aerodigestive symptoms, JAMA Otolaryngol Head Neck Surg, 139, 903, 10.1001/jamaoto.2013.4171 Spergel, 2009, 14 years of eosinophilic esophagitis: clinical features and prognosis, J Pediatr Gastroenterol Nutr, 48, 30, 10.1097/MPG.0b013e3181788282 Dellon, 2014, Prevalence of eosinophilic esophagitis in the United States, Clin Gastroenterol Hepatol, 12, 589, 10.1016/j.cgh.2013.09.008 Alexander, 2014, Twin and family studies reveal strong environmental and weaker genetic cues explaining heritability of eosinophilic esophagitis, J Allergy Clin Immunol, 134, 1084, 10.1016/j.jaci.2014.07.021 González-Cervera, 2017, Association between atopic manifestations and eosinophilic esophagitis: a systematic review and meta-analysis, Ann Allergy Asthma Immunol, 118, 582, 10.1016/j.anai.2017.02.006 Lucendo, 2014, Relation between eosinophilic esophagitis and oral immunotherapy for food allergy: a systematic review with meta-analysis, Ann Allergy Asthma Immunol, 113, 624, 10.1016/j.anai.2014.08.004 Simon, 2016, Eosinophilic esophagitis is characterized by a non-IgE-mediated food hypersensitivity, Allergy, 71, 611, 10.1111/all.12846 Clayton, 2014, Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE, Gastroenterology, 147, 602, 10.1053/j.gastro.2014.05.036 Lucendo, 2014, Systematic review: the association between eosinophilic oesophagitis and coeliac disease, Aliment Pharmacol Ther, 40, 422 Hommeida, 2017, The association between celiac disease and eosinophilic esophagitis: Mayo experience and meta-analysis of the literature, J Pediatr Gastroenterol Nutr, 65, 58, 10.1097/MPG.0000000000001499 Jensen, 2015, Increased risk of esophageal eosinophilia and eosinophilic esophagitis in patients with active celiac disease on biopsy, Clin Gastroenterol Hepatol, 13, 1426, 10.1016/j.cgh.2015.02.018 Lucendo, 2015, Disease associations in eosinophilic oesophagitis and oesophageal eosinophilia, Best Pract Res Clin Gastroenterol, 29, 759, 10.1016/j.bpg.2015.06.010 Croese, 2003, Clinical and endoscopic features of eosinophilic esophagitis in adults, Gastrointest Endosc, 58, 516, 10.1067/S0016-5107(03)01870-4 Kahn, 2015, Exercise-induced chest pain: an atypical manifestation of eosinophilic esophagitis, Am J Med, 128, 196, 10.1016/j.amjmed.2014.08.007 Gonsalves, 2006, Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis, Gastrointest Endosc, 64, 313, 10.1016/j.gie.2006.04.037 Shah, 2009, Histopathologic variability in children with eosinophilic esophagitis, Am J Gastroenterol, 104, 716, 10.1038/ajg.2008.117 Lim, 2004, White specks in the esophageal mucosa: an endoscopic manifestation of non-reflux eosinophilic esophagitis in children, Gastrointest Endosc, 59, 835, 10.1016/S0016-5107(04)00364-5 Straumann, 2004, Eosinophilic esophagitis: red on microscopy, white on endoscopy, Digestion, 70, 109, 10.1159/000080934 Salek, 2015, Endoscopic appearance and location dictate diagnostic yield of biopsies in eosinophilic oesophagitis, Aliment Pharmacol Ther, 41, 1288, 10.1111/apt.13201 Liacouras, 2005, Eosinophilic esophagitis: a 10-year experience in 381 children, Clin Gastroenterol Hepatol, 3, 1198, 10.1016/S1542-3565(05)00885-2 Kim, 2012, The prevalence and diagnostic utility of endoscopic features of eosinophilic esophagitis: a meta-analysis, Clin Gastroenterol Hepatol, 10, 988, 10.1016/j.cgh.2012.04.019 Kaur, 2017, Utility of gastric and duodenal biopsies during follow-up endoscopy in children with eosinophilic esophagitis, J Pediatr Gastroenterol Nutr, 65, 399, 10.1097/MPG.0000000000001528 Dellon, 2007, Variability in diagnostic criteria for eosinophilic esophagitis: a systematic review, Am J Gastroenterol, 102, 2300, 10.1111/j.1572-0241.2007.01396.x Dellon, 2015, Distribution and variability of esophageal eosinophilia in patients undergoing upper endoscopy, Mod Pathol, 28, 383, 10.1038/modpathol.2014.110 Collins, 2017, Newly developed and validated eosinophilic esophagitis histology scoring system and evidence that it outperforms peak eosinophil count for disease diagnosis and monitoring, Dis Esophagus, 30, 1 Schoepfer, 2014, Development and validation of a symptom-based activity index for adults with eosinophilic esophagitis, Gastroenterology, 147, 1255, 10.1053/j.gastro.2014.08.028 Safroneeva, 2016, Symptoms have modest accuracy in detecting endoscopic and histologic remission in adults with eosinophilic esophagitis, Gastroenterology, 150, 581, 10.1053/j.gastro.2015.11.004 Hirano, 2013, Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system, Gut, 62, 489, 10.1136/gutjnl-2011-301817 Van Rhijn, 2016, The Endoscopic Reference Score shows modest accuracy to predict histologic remission in adult patients with eosinophilic esophagitis, Neurogastroenterol Motil, 28, 1714, 10.1111/nmo.12872 Rodríguez-Sánchez, 2017, The Endoscopic Reference Score shows modest accuracy to predict either clinical or histological activity in adult patients with eosinophilic oesophagitis, Aliment Pharmacol Ther, 45, 300, 10.1111/apt.13845 Schoepfer, 2015, How do gastroenterologists assess overall activity of eosinophilic esophagitis in adult patients?, Am J Gastroenterol, 110, 402, 10.1038/ajg.2015.32 Straumann, 2003, Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years, Gastroenterology, 125, 1660, 10.1053/j.gastro.2003.09.024 Assa’ad, 2007, Pediatric patients with eosinophilic esophagitis: an 8-year follow-up, J Allergy Clin Immunol, 119, 731, 10.1016/j.jaci.2006.10.044 Lipka, 2016, Impact of diagnostic delay and other risk factors on eosinophilic esophagitis phenotype and esophageal diameter, J Clin Gastroenterol, 50, 134, 10.1097/MCG.0000000000000297 Schoepfer, 2013, Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner, Gastroenterology, 145, 1230, 10.1053/j.gastro.2013.08.015 Dellon, 2014, A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease, Gastrointest Endosc, 79, 577, 10.1016/j.gie.2013.10.027 Van Rhijn, 2014, Prevalence of esophageal motility abnormalities increases with longer disease duration in adult patients with eosinophilic esophagitis, Neurogastroenterol Motil, 26, 1349, 10.1111/nmo.12400 Abu-Sultaneh, 2011, Fluticasone and food allergen elimination reverse sub-epithelial fibrosis in children with eosinophilic esophagitis, Dig Dis Sci, 56, 97, 10.1007/s10620-010-1259-5 Lieberman, 2012, Dietary therapy can reverse esophageal subepithelial fibrosis in patients with eosinophilic esophagitis: a historical cohort, Allergy, 67, 1299, 10.1111/j.1398-9995.2012.02881.x Moawad, 2013, Randomized controlled trial comparing aerosolized swallowed fluticasone to esomeprazole for esophageal eosinophilia, Am J Gastroenterol, 108, 366, 10.1038/ajg.2012.443 Vazquez-Elizondo, 2013, The outcome of patients with oesophageal eosinophilic infiltration after an eight-week trial of a proton pump inhibitor, Aliment Pharmacol Ther, 38, 1312, 10.1111/apt.12513 Gutiérrez-Junquera, 2016, High prevalence of response to proton-pump inhibitor treatment in children with esophageal eosinophilia, J Pediatr Gastroenterol Nutr, 62, 704, 10.1097/MPG.0000000000001019 Lucendo, 2016, Efficacy of proton pump inhibitor drugs for inducing clinical and histologic remission in patients with symptomatic esophageal eosinophilia: a systematic review and meta-analysis, Clin Gastroenterol Hepatol, 14, 13, 10.1016/j.cgh.2015.07.041 Gómez-Torrijos, 2016, The efficacy of step-down therapy in adult patients with proton pump inhibitor-responsive oesophageal eosinophilia, Aliment Pharmacol Ther, 43, 534, 10.1111/apt.13496 Molina-Infante, 2015, Long-term loss of response in proton pump inhibitor-responsive esophageal eosinophilia is uncommon and influenced by CYP2C19 genotype and rhinoconjunctivitis, Am J Gastroenterol, 110, 1567, 10.1038/ajg.2015.314 Tan, 2015, Steroids therapy for eosinophilic esophagitis: systematic review and meta-analysis, J Dig Dis, 16, 431, 10.1111/1751-2980.12265 Chuang, 2015, Topical steroid therapy for the treatment of eosinophilic esophagitis (EoE): a systematic review and meta-analysis, Clin Transl Gastroenterol, 6, e82, 10.1038/ctg.2015.9 Murali, 2016, Topical steroids in eosinophilic esophagitis: systematic review and meta-analysis of placebo-controlled randomized clinical trials, J Gastroenterol Hepatol, 31, 1111, 10.1111/jgh.13281 Sawas, 2015, Systematic review with meta-analysis: pharmacological interventions for eosinophilic oesophagitis, Aliment Pharmacol Ther, 41, 797, 10.1111/apt.13147 Dellon, 2012, Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis, Gastroenterology, 143, 321, 10.1053/j.gastro.2012.04.049 Miehlke, 2016, A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis, Gut, 65, 390, 10.1136/gutjnl-2014-308815 Dellon, 2017, Budesonide oral suspension improves symptomatic, endoscopic, and histologic parameters compared with placebo in patients with eosinophilic esophagitis, Gastroenterology, 152, 776, 10.1053/j.gastro.2016.11.021 Straumann, 2011, Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis, Clin Gastroenterol Hepatol, 9, 400, 10.1016/j.cgh.2011.01.017 Butz, 2014, Efficacy, dose reduction, and resistance to high-dose fluticasone in patients with eosinophilic esophagitis, Gastroenterology, 147, 324, 10.1053/j.gastro.2014.04.019 Andreae, 2016, Swallowed fluticasone propionate is an effective long-term maintenance therapy for children with eosinophilic esophagitis, Am J Gastroenterol, 111, 1187, 10.1038/ajg.2016.238 Golekoh, 2016, Adrenal insufficiency after chronic swallowed glucocorticoid therapy for eosinophilic esophagitis, J Pediatr, 170, 240, 10.1016/j.jpeds.2015.11.026 Philla, 2015, Swallowed glucocorticoid therapy for eosinophilic esophagitis in children does not suppress adrenal function, J Pediatr Endocrinol Metab, 28, 1101, 10.1515/jpem-2014-0260 Kelly, 1995, Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula, Gastroenterology, 109, 1503, 10.1016/0016-5085(95)90637-1 Arias, 2014, Efficacy of dietary interventions for inducing histologic remission in patients with eosinophilic esophagitis: a systematic review and meta-analysis, Gastroenterology, 146, 1639, 10.1053/j.gastro.2014.02.006 Spergel, 2002, The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis, J Allergy Clin Immunol, 109, 363, 10.1067/mai.2002.121458 Spergel, 2012, Identification of causative foods in children with eosinophilic esophagitis treated with an elimination diet, J Allergy Clin Immunol, 130, 461, 10.1016/j.jaci.2012.05.021 Van Rhijn, 2015, Evaluation of allergen-microarray-guided dietary intervention as treatment of eosinophilic esophagitis, J Allergy Clin Immunol, 136, 1095, 10.1016/j.jaci.2015.02.038 Philpott, 2016, Allergy tests do not predict food triggers in adult patients with eosinophilic oesophagitis. A comprehensive prospective study using five modalities, Aliment Pharmacol Ther, 44, 223, 10.1111/apt.13676 Kagalwalla, 2006, Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis, Clin Gastroenterol Hepatol, 4, 1097, 10.1016/j.cgh.2006.05.026 Lucendo, 2015, Meta-analysis-based guidance for dietary management in eosinophilic esophagitis, Curr Gastroenterol Rep, 17, 464, 10.1007/s11894-015-0464-y Molina-Infante, 2014, Four-food group elimination diet for adult eosinophilic esophagitis: a prospective multicenter study, J Allergy Clin Immunol, 134, 1093, 10.1016/j.jaci.2014.07.023 Kagalwalla, 2017, Efficacy of a 4-food elimination diet for children with eosinophilic esophagitis, Clin Gastroenterol Hepatol, 15, 1698, 10.1016/j.cgh.2017.05.048 Molina-Infante, 2017, Step-up empiric elimination diet for pediatric and adult eosinophilic esophagitis: the 2-4-6 study, J Allergy Clin Immunol Lucendo, 2013, Empiric 6-food elimination diet induced and maintained prolonged remission in patients with adult eosinophilic esophagitis: a prospective study on the food cause of the disease, J Allergy Clin Immunol, 131, 797, 10.1016/j.jaci.2012.12.664 Gonsalves, 2012, Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors, Gastroenterology, 142, 1451, 10.1053/j.gastro.2012.03.001 Kagalwalla, 2011, Identification of specific foods responsible for inflammation in children with eosinophilic esophagitis successfully treated with empiric elimination diet, J Pediatr Gastroenterol Nutr, 53, 145, 10.1097/MPG.0b013e31821cf503 Moawad, 2017, Systematic review with meta-analysis: endoscopic dilation is highly effective and safe in children and adults with eosinophilic oesophagitis, Aliment Pharmacol Ther, 46, 96, 10.1111/apt.14123 Molina-Infante, 2017, Eosinophilic esophagitis: what can we learn from Crohn's disease?, United Eur Gastroenterol J, 5, 762, 10.1177/2050640616672953 Lucendo, 2016, Dual response to dietary/topical steroid and proton pump inhibitor therapy in adult patients with eosinophilic esophagitis, J Allergy Clin Immunol, 137, 931, 10.1016/j.jaci.2015.07.033 Sodikoff, 2016, Proton pump inhibitor-responsive esophageal eosinophilia does not preclude food-responsive eosinophilic esophagitis, J Allergy Clin Immunol, 137, 631, 10.1016/j.jaci.2015.07.008 Netzer, 2007, Corticosteroid-dependent eosinophilic oesophagitis: azathioprine and 6-mercaptopurine can induce and maintain long-term remission, Eur J Gastroenterol Hepatol, 19, 865, 10.1097/MEG.0b013e32825a6ab4 Lucendo, 2011, Montelukast was inefficient in maintaining steroid-induced remission in adult eosinophilic esophagitis, Dig Dis Sci, 56, 3551, 10.1007/s10620-011-1775-y Alexander, 2017, Montelukast does not maintain symptom remission after topical steroid therapy for eosinophilic esophagitis, Clin Gastroenterol Hepatol, 15, 214, 10.1016/j.cgh.2016.09.013 Straumann, 2013, Anti-eosinophil activity and clinical efficacy of the CRTH2 antagonist OC000459 in eosinophilic esophagitis, Allergy, 68, 375, 10.1111/all.12096 Straumann, 2010, Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial, Gut, 59, 21, 10.1136/gut.2009.178558 Assa’ad, 2011, An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis, Gastroenterology, 141, 1593, 10.1053/j.gastro.2011.07.044 Spergel, 2012, Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial, J Allergy Clin Immunol, 129, 456, 10.1016/j.jaci.2011.11.044 Rothenberg, 2015, Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis, J Allergy Clin Immunol, 135, 500, 10.1016/j.jaci.2014.07.049 Straumann, 2008, Anti-TNF-alpha (infliximab) therapy for severe adult eosinophilic esophagitis, J Allergy Clin Immunol, 122, 425, 10.1016/j.jaci.2008.06.012